How many insider trades does FilingIQ track for HAE?

FilingIQ tracks 837 Form 4 insider transactions for HAE (HAEMONETICS CORP), covering filings from Jan 22, 2015 onwards. 1 of those were filed in the last 90 days.

Are HAE insiders net buyers or net sellers?

Across the full Form 4 history for HAE, 2 transactions (0%) were open-market purchases and 385 (46%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does HAE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is HAE in?

HAEMONETICS CORP (HAE) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $2.92B.

HAE insider trading

NYSE Healthcare

HAEMONETICS CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

837

Last 90 days

Buys / sells

0% / 46%

Market cap

$2.92B

About HAEMONETICS CORP

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Company website: www.haemonetics.com

HAE insider activity at a glance

FilingIQ has scored 837 insider transactions for HAE since Jan 22, 2015. The most recent filing in our index is dated May 1, 2026.

Across the full history, 2 open-market purchases and 385 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on HAE insider trades is 54.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live HAE trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding HAE

SG Capital Management LLC

$51.72M · 6.5% of AUM

OSTERWEIS CAPITAL MANAGEMENT INC

$46.60M · 2.3% of AUM

READYSTATE ASSET MANAGEMENT LP

$29.27M · 1.0% of AUM

Frequently asked

How many insider trades does FilingIQ track for HAE?: FilingIQ tracks 837 Form 4 insider transactions for HAE (HAEMONETICS CORP), covering filings from Jan 22, 2015 onwards. 1 of those were filed in the last 90 days.
Are HAE insiders net buyers or net sellers?: Across the full Form 4 history for HAE, 2 transactions (0%) were open-market purchases and 385 (46%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does HAE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is HAE in?: HAEMONETICS CORP (HAE) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $2.92B.

Methodology & sources

Every HAE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.